Immunovant Inc
Contact Information
Company Details
Location Type: Single Location
Industry: Biological Products, Except Diagnostic Substances
Ownership: Public
Year Founded: 2018
Sales Range: $10,000,000 to $24,999,999
Employees: 100 to 250
Is This Your Customer, Supplier, Or Partner?
Is This Your Business?
Is This Your Customer, Supplier, Or Partner?
Pull Their Credit Report CREATE A FREE ACCOUNT
Company Credit Alerts
Recent Alerts
Credit Risk Increase
No
Overall Payments
No
Peer Payments
No
Bankruptcy
No
Tax Liens
No
UCC Filings
No
See All Credit Alerts On Your Customers From The Past 12 Months
Company News
Latest News
Immunovant Awarded U.S. Patent for IMVT-1402
Mar 12 2024
Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters' Option to Purchase Additional Shares
Oct 2 2023
Immunovant to raise $450M from public offering and private placement
Seeking Alpha Latest
Sep 28 2023
Immunovant Announces Pricing of $450 Million Common Stock Financing
Sep 28 2023
Analyze Your Entire AR Portfolio with One Free Credit Tool
LEARN MORECompany Buying Behavior
Overall Company Spend
Credit Analysis Tip
Purchases of key products and services provides insight into whether a business is growing or declining financially. Analyzing spending enables creditors predict risk scenarios before other credit analysis methods. Lean how in our latest case study.
DOWNLOAD CASE STUDYCompany Credit Alerts
Recent Alerts
Credit Risk Increase
No
Overall Payments
No
Peer Payments
No
Bankruptcy
No
Tax Liens
No
UCC Filings
No
See All Credit Alerts On Your Customers From The Past 12 Months
Sales Insights
More Businesses Like this
Discover other companies in the same industry you can sell to: